“One of the beauties of being in biotech is that at the end of what you do you improve the lives of debilitating diseases,” said John Temperato, CEO of 9 Meter BioPharma. Temperato and his team of researchers have spent years working on a cure for celiac disease, which impacts 3.5 million people in the United States alone.